-
Recombinant Mouse IFN-γ: Advancing Tumor Immunity Assays
2026-07-01
Explore how high-purity Recombinant Mouse IFN-γ enables translational researchers to dissect antigen presentation, immune escape, and the immunometabolic crosstalk central to MASH-HCC. This thought-leadership article frames the scientific problem, delivers mechanistic insight, and provides strategic experimental guidance, all while positioning APExBIO’s IFN-γ as an indispensable tool for next-generation immunotherapy research.
-
Applied Uses of c-Myc tag Peptide: Assays, Workflows & Troub
2026-07-01
The c-Myc tag Peptide from APExBIO redefines immunoassay precision and transcription factor studies through its robust displacement capability and high purity. This guide details protocol enhancements, advanced applications, and troubleshooting strategies—bridging core workflows to cutting-edge autophagy and transcription factor regulation research.
-
S Tag Peptide (A6007): Technical Guidance for Tagging Workfl
2026-06-30
S Tag Peptide enhances recombinant protein solubility and enables reliable detection using anti-S-Tag antibodies, making it suitable for protein expression and purification workflows in molecular biology. It is not recommended for ethanol-based applications or protocols requiring long-term solution storage. Researchers should follow defined storage and handling conditions to maintain performance.
-
CD40–STING–TRAF2 Axis Regulates B Cell Activation in ESCC TL
2026-06-30
This study uncovers the competitive binding of CD40 and STING with TRAF2 as a driver of IRF4-mediated B cell activation within tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma (ESCC). These findings clarify key molecular mechanisms underlying TLS antitumor activity and inform future biomarker and therapeutic development.
-
RIPA Lysis Buffer Strong: Optimizing Protein Extraction Work
2026-06-29
Unlock robust protein extraction from challenging tissues and cells with RIPA Lysis Buffer (Strong, without inhibitors). Discover how its customizable inhibitor strategy and detergent profile enable precise, high-yield sample preparation for advanced immunological assays, as demonstrated in recent neuroscience models.
-
AhR Antagonism Mitigates MEHP-Induced Ovarian Toxicity in Mi
2026-06-29
This study demonstrates that mono(2-ethylhexyl) phthalate (MEHP) disrupts follicle growth and estrogen production in mouse ovarian antral follicles via activation of the aryl hydrocarbon receptor (AhR). Notably, AhR antagonism using CH 223191 partially rescues these reproductive impairments, offering mechanistic insight into environmental phthalate toxicity.
-
Topotecan and Carboplatin Combinations in Ovarian Cancer The
2026-06-28
This article analyzes the Cochrane systematic review evaluating topotecan in combination with platinum-based agents like carboplatin for ovarian cancer. The review provides robust evidence on survival outcomes and progression metrics, revealing both the therapeutic potential and toxicity considerations of combined regimens.
-
Recombinant Mouse IFN-γ for Precision Antigen Presentation A
2026-06-27
Harness Recombinant Mouse IFN-γ to dissect immune evasion in metabolic liver cancer with robust, reproducible antigen presentation workflows. Discover advanced protocol enhancements and troubleshooting strategies that maximize immunomodulatory cytokine research outcomes.
-
Baicalein for Precision Cancer and Inflammation Research: Me
2026-06-26
Explore how Baicalein, a potent 12-LOX inhibitor, advances apoptosis and inflammation research. This article uniquely analyzes cross-pathway modulation and assay design considerations for scientists.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Optimizing mRNA Delivery in
2026-06-26
EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers to restore tumor suppressor function with unmatched stability and immune evasion, accelerating advanced cancer workflows. Its Cap1 structure and pseudouridine modifications enable robust, reproducible PTEN expression, making it a preferred mRNA tool for investigating PI3K/Akt pathway inhibition and drug resistance reversal.
-
Anlotinib Hydrochloride Suppresses Tumor Angiogenesis via Mu
2026-06-25
This study demonstrates that Anlotinib hydrochloride robustly inhibits tumor angiogenesis by targeting VEGFR2, PDGFRβ, and FGFR1, disrupting endothelial cell migration and tube formation. The findings reveal superior anti-angiogenic efficacy compared to established tyrosine kinase inhibitors, highlighting Anlotinib's translational potential in cancer research.
-
UBE2F-SAG Axis Drives RHEB Neddylation and mTORC1 in Liver C
2026-06-25
This study identifies RHEB as a novel neddylation substrate of the UBE2F-SAG E2/E3 axis, revealing its mechanistic enhancement of mTORC1 activity and its role in promoting liver tumorigenesis. The findings clarify how targeting the neddylation pathway may offer new therapeutic strategies for hepatocellular carcinoma and related disorders.
-
Sodium Citrate in SERS Nanocluster Assembly: Protocols & Tip
2026-06-24
Sodium citrate is pivotal for reproducible SERS nanocluster substrate fabrication, acting as both a precise buffering agent and a metal ion chelator. This guide distills advanced protocols and troubleshooting strategies, leveraging recent breakthroughs to maximize sensitivity and consistency in 3D nanofabrication.
-
Sodium Ascorbate: Advancing Tumor Necrosis Models in Cancer
2026-06-23
Explore how Sodium Ascorbate, a mineral salt of ascorbic acid, enables advanced modeling of cancer cell necrosis and ROS-mediated mechanisms. This article provides unique insights for translational research, bridging in vitro and in vivo findings to future assay development.
-
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor M
2026-06-23
This study introduces a patient-specific gastric cancer assembloid platform that integrates matched tumor organoids with stromal cell subpopulations, enabling more physiologically relevant analysis of tumor–stroma interactions and drug resistance. The findings highlight the critical impact of stromal components on gene expression and therapeutic response, offering a valuable preclinical model for personalized drug screening and mechanistic investigation.